palliative

(redirected from palliatively)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

palliative

 [pal´e-ah-tiv]
1. giving relief but not curing.
2. a drug with this effect.

pal·li·a·tive

(pal'ē-ă-tiv),
Reducing the severity of; denoting the alleviation of symptoms without curing the underlying disease.

palliative

/pal·li·a·tive/ (pal´e-a″tiv) affording relief; also, a drug that so acts.

palliative

(păl′ē-ā′tĭv, -ē-ə-tĭv)
adj.
1. Tending or serving to palliate.
2. Alleviating the symptoms of a disease or disorder, especially one that is terminal, when a cure is not available.
n.
One that palliates, especially a palliative drug or medicine.

pal′li·a′tive·ly adv.

palliative

adjective Referring to treatment to relieve or ameliorate the symptoms of a painful condition, usually understood to mean of terminal cancer, especially the deep-seated bone pain of metastatic breast cancer.

Pronunciation:
Medspeak-UK: pronounced, PAY lee uh tive.
Medspeak-US: pronounced, PAL ee uh tive.

palliative

Radiation oncology adjective Referring to treatment to relieve Sx of a disease but not to cure it, especially alleviating pain

pal·li·a·tive

(pal'ē-ă-tiv)
Reducing the severity of; denoting the alleviation of symptoms without curing the underlying disease.

Palliative

Referring to any type of treatment that is given to relieve the symptoms of a disease rather than to cure it.

palliation

; palliative therapies that reduce symptom severity, but do not cure

pal·li·a·tive

(pal'ē-ă-tiv)
Reducing the severity of pain or discomfort.

palliative (pal´ēətiv),

n an alleviating measure.

palliative

affording relief; also, a drug that so acts.
References in periodicals archive ?
If a formerly "curative" therapy is used palliatively, outcome measures may categorize it as a failed therapy unless we recognize that it was never intended to cure.
In a cancer patient who is not a surgical candidate, a colorectal stent can be used palliatively, to avoid the need for a colostomy and significantly improve the patient's quality of life," Longfield concluded.
These costs were due mainly to the two new clinical trials for non-small cell lung cancer patients ineligible for curative treatment who are being treated palliatively (NSCLC) and patients with brain metastases from non-small cell lung cancer, as well as the ongoing pediatric glioma trial.